510(k) Report

510(k) · Cleared

Cleared

Core Control Pad, Core Series SW V3.4 Installation Kit, Core, Core Mobile

K133641510(k) SpecialCleared Dec 20, 201323-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Volcano Corporation · IYO System, Imaging, Pulsed Echo, Ultrasonic

Cleared on Dec 20, 2013 after a 23-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below). 5 later devices descend from it.

Decided
Dec 20, 2013
Review
23 days
Class
Class II
Product code
IYO
Recalls
None
Predicates
1

5 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2015: 2 descendants cleared2014: 1 descendant cleared2017: 2 descendants cleared2010201520202025
  1. This deviceK133641 Core Control Pad, Core Series SW V3.4 Installation Kit, Core, Core…Volcano Corporation · 2013
  2. Descendant · cites it directly · 3 of its ownK140291 Volcano Core Control Pad, Accessory to the Volcano S5/S5I…Volcano Corporation · 2014
  3. Descendant · cites it directly · 2 of its ownK153369 SW v3.5 Install Kit, CORE Mobile, SW v3.5 Install Kit, CORE, SW v3.5…Volcano Corporation · 2015
  4. Descendant · 2 generations on · 1 of its ownK170385 CORE M2 Vascular SystemVolcano Corporation · 2017
  5. Descendant · 2 generations on · 0 of its ownK172455 CORE M2 Vascular System, CORE M2 Software v4.2 Upgrade Kit, CORE M2…Volcano Corporation · 2017 · Recalled
  6. Descendant · cites it directly · 0 of its ownK152582 CORE FM System, Patient Interface Module (OPIM), Hemodynamic…Volcano Corporation · 2015

Most influential descendants

Showing 5 of 5 · See all
  • K140291Volcano Core Control Pad, Accessory to the Volcano S5/S5I Intravascular Ultrasound…Volcano Corporation · 2014 · cites it directly3descendants
  • K153369SW v3.5 Install Kit, CORE Mobile, SW v3.5 Install Kit, CORE, SW v3.5 Install Kit, s5izVolcano Corporation · 2015 · cites it directly2descendants
  • K170385CORE M2 Vascular SystemVolcano Corporation · 2017 · 2 generations on1descendant
  • K172455CORE M2 Vascular System, CORE M2 Software v4.2 Upgrade Kit, CORE M2 Software v4.2…Volcano Corporation · 2017 · 2 generations on0descendants
  • K152582CORE FM System, Patient Interface Module (OPIM), Hemodynamic Converter BoxVolcano Corporation · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K133641Core Control Pad, Core Series SW V3.4 Installation Kit, Core, Core MobileVolcano Corporation2013—
+1K140291Volcano Core Control Pad, Accessory to the Volcano S5/S5I Intravascular…Volcano Corporation2014—
+1K153369SW v3.5 Install Kit, CORE Mobile, SW v3.5 Install Kit, CORE, SW v3.5 Install…Volcano Corporation2015—
+2K170385CORE M2 Vascular SystemVolcano Corporation2017—
+2K172455CORE M2 Vascular System, CORE M2 Software v4.2 Upgrade Kit, CORE M2 Software…Volcano Corporation20171
+1K152582CORE FM System, Patient Interface Module (OPIM), Hemodynamic Converter BoxVolcano Corporation2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201410
201520
201720
FIG. 1 — Lineage of K133641, 2013–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYO device

  1. #1 K243937 Accuro 3Sscore 20.5 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK133141Volcano s5/ssi CORE and CORE Mobile Series Precision Guided Therapy Systems
Not matched in our reading of the summary (scans can blur digits), so it is kept off the family tree

What descends from it? (5)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K140291Volcano Core Control Pad, Accessory to the Volcano S5/S5I Intravascular Ultrasound…Volcano Corporation20143
K153369SW v3.5 Install Kit, CORE Mobile, SW v3.5 Install Kit, CORE, SW v3.5 Install Kit, s5izVolcano Corporation20152
K152582CORE FM System, Patient Interface Module (OPIM), Hemodynamic Converter BoxVolcano Corporation20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K140291 (Volcano Corporation, 2014) has gone furthest, with 3 descendants of its own.

How does its category compare?

All IYO devices

IYO System, Imaging, Pulsed Echo, Ultrasonic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · IYO

7in 2025

2007: 202008: 142009: 132010: 152011: 112012: 152013: 172014: 142015: 192016: 102017: 192018: 142019: 132020: 112021: 152022: 52023: 112024: 102025: 72026 (partial year): 10
2007high 20 (2007) · low 5 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYO

171in 2025

2007: 17 days median2008: 36 days median2009: 79 days median2010: 113 days median2011: 69 days median2012: 68 days median2013: 50 days median2014: 63 days median2015: 46 days median2016: 36 days median2017: 72 days median2018: 56 days median2019: 59 days median2020: 57 days median2021: 64 days median2022: 190 days median2023: 177 days median2024: 220 days median2025: 171 days median2026 (partial year): 139 days median
2007high 220 (2024) · low 17 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYO

1in 2022

2007: 42008: 52009: 92010: 82012: 22013: 32014: 22015: 12018: 12019: 12021: 112022: 12026 (partial year): 1
2007high 11 (2021) · low 0 (2011)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYO

485in 2025

2007: 392008: 202009: 272010: 202011: 582012: 782013: 4362014: 3042015: 2682016: 2542017: 2382018: 3682019: 5372020: 4982021: 6172022: 5112023: 5272024: 6402025: 485
2007high 640 (2024) · low 20 (2008)2025

MAUDE reports naming product code IYO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072017439
20081436520
20091379927
201015113820
20111169058
20121568278
201317503436
201414632304
201519461268
201610360254
201719720238
201814561368
201913591537
202011570498
2021156411617
202251901511
2023111770527
2024102200640
202571710485
2026101391—

What is it indicated for?

The Volcano CORE/CORE Mobile Series Intravascular Imaging and Pressure System is used for the qualitative and quantitative evaluation of vascular morphology in the coronary arteries and vessels of the peripheral vasculature. It is also indicated as an adjunct to conventional angiographic procedures to provide an image of vessel lumen and wall structures. ChromaFlo is indicated for qualitative blood flow information from peripheral and coronary…

Read the full statement (224 words)

The Volcano CORE/CORE Mobile Series Intravascular Imaging and Pressure System is used for the qualitative and quantitative evaluation of vascular morphology in the coronary arteries and vessels of the peripheral vasculature. It is also indicated as an adjunct to conventional angiographic procedures to provide an image of vessel lumen and wall structures.

ChromaFlo is indicated for qualitative blood flow information from peripheral and coronary vasculature; flow information can be an adjunct to other methods of estimating blood flow and blood perfusion.

VH-IVUS intended to be used in conjunction with imaging catheters during diagnostic ultrasound imaging of the peripheral and coronary vasculature. The Volcano VH IVUS System is intended to semi-automatically visualize boundary features and perform spectral analysis of RF ultrasound signals of vascular features that the user may wish to examine more closely during routine diagnostic ultrasound imaging examinations.

The pressure feature is intended for use in all blood vessels, including coronary and peripheral arteries, to measure intravascular blood pressure during diagnostic angiography and/or interventional procedures.

Rotational 45MHz feature is intended for the qualitative and quantitative evaluation of vascular morphology in the coronary arteries and vasculature. As an adjunct to conventional angiographic procedures to provide an image of the vessel lumen and wall structures. The pullback feature of the PIMr withdraws the imaging core within the protective sheath for a maximum of 15 cm.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K133641: Core Control Pad, Core Series SW V3.4 Installation Kit, Core, Core Mobile.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K133641

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026